95
ୋɚືcᏨ᜕ყʷ
ତ
ر
͉ጐၾආᏨ᜕ዚ
ܔ
ͭྼሯΥЪᗫ
ڷ
dኪ୦Ԩіϗ௰อҦஔd˸л೯࢝
ၾყΝӉʘᏨ᜕ҦஔdԨᑘ፬ყীึ࢝ତੂБ᜕dʺҢ೯ʘᏨ᜕ঐඎf
݁ഄၾϓ
؈
ɓe ۜჯਹ
ɓଉʷၾ
ߕ
ۜᖹ
၍ي
ଣ҅
FDA
ʘ
ΥЪ
1.
100
Ї
101
ϋ
ݼ
ࡰЇ
ߕ
FDA
ۜτ
Όၾᐄቮʕː
CFSAN
ආБ
މ
ಂ
ɓϋٙΝӺ
ࠇ
dϤ
ܝ
˸ᒗሗ
CFSAN
༵ᖹᏨ᜕ʃଡ଼
ࠋ
பɛ
Jon Wong
௹ɻԸၽdආБۜᏨ᜕Ҧஔʹ
ݴ
f
2. 102
ϋϋ
ڋ
ყග೯͛ॲГᚆ̲४ဲӴ᜕ўϞᕐ↾ᶶ
DCD
ԫdΝϋֵ
lzᖑ೯
ذ
ۜʕဲЧ̋ზၠ९ԫdԫ೯͛ࣛѩஹᖩ
ߕ
FDA
ਖ਼d
п͉ҞΪᏐdՈ༺ϓᏨ᜕ყʷʘͦٙf
ɚܵᚃਞၾʮ֛ʱؓʷኪึ
AOAC
AOAC
݊ყගᗫۜτΌᏨ᜕ʘᛆ
۾
ଡ଼ᔌd͉
ڐ
ϋԸӊϋѩ
ݼ
ࡰ̈ࢩί
ߕ
ᑘБʘϋึdீཀɹ᎘စႭʿኣజሞ˖೯
ڌ
d࢝ତ͉ӺᏨ᜕ϓ
؈
dԨၾ
ყਖ਼ʹ
ݴ
ʝਗfϤ̮dӊϋ
ߕ
ϋึޫᚠϞਖ਼᙮ࣛ
ݬ
ʿึᙄ܃Զၽᝄʱึᑘ፬ึ
ᙄdᜑͪ
ߕ
AOAC
ᐼึ࿁ၽᝄʘࠠൖf
ɚe ᖹۜჯਹ
ɓ
102
ϋගᐏᒗਞၾ
WHO
ਜਹΥЪʕː
WHO Collaborating Center
ߵ
͛
ي
Ⴁኒᅺ၍ՓӺ
ה
National Institute for Biological Standards and Control,
NIBSC
ᑘ፬ʘ
3rd WHO International Standard for B19V for NAT-based assays
ʿ
2nd WHO International Standard for HAV for NAT-based assays
ყΝᅺ
֛Ӻf
ɚ͉
102
ϋ
5
˜
29-31
˚ᑘ፬
2013
ყ
ߴޥ
Ꮸ᜕ʿ೯อҦஔყীึd
ึʕᒗሗ
ج
eˢe˚e൳ʿlzਖ਼ఱɛळஷෂ
ݑ
षʘ
ݴ
Бषኪeอ
ߴޥ
೯e
ۜሯᏨ᜕e͛
ي
୕
ࠇ
ʱؓᏐ͜ʿၽᝄ
ߴޥ
͛
ي
ᖹۜۜ၍Ꮸ᜕ၾ༟ৃ၍ଣӻ୕ഃᙄ
ᕚආБစᑺdԨၾlz˴၍ዚᗫʿପኪ
ޢ
ආБҦஔʹ
ݴ
f
Jon Wong
௹ɻႇආБۜᏨ᜕Ҧஔʹ
ݴ